Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 821-827

  Holstein, Joerg H ^a   Herrmann, Markus ^a,b   Splett, Christina ^a   Herrmann, Wolfgang ^a   Garcia, Patric ^a   Histing, Tina ^a   Klein, Moritz ^a   Kurz, Karsten ^c   Siebel, Thomas ^c   Pohlemann, Tim ^a   Menger, Michael D ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Orthopaedic Surgery   (Germany)

Author keywords

B vitamins; Biomechanics; Bone mineral density; Histomorphometry; Hyperhomocysteinemia

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ANTHROPOMETRY; ARTICLE; BIOMECHANICS; BLOOD SAMPLING; BONE DENSITY; BONE STRUCTURE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR HEAD; FOLIC ACID BLOOD LEVEL; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; TRABECULAR BONE; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BONE DENSITY; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; VITAMIN B 12; VITAMIN B 6;

EID: 77953218918     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.155     Document Type: Article

References (43)

1. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19:217-246
2. De Bree A, Verschuren WM, Blom HJ, Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001;154:150-154 (Pubitemid 32643130)
3. Herrmann W, Quast S, Ullrich M, Schultze H, Bodis M, Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of Bvitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 1999;144:91-101.
4. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049-1057
5. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006;166:88-94.
6. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-2049
7. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350:2033-2041
8. Bode MK, Laitinen P, Risteli J, Uusimaa P, Juvonen T. Atherosclerosis, type 1 collagen cross-linking and homocysteine. Atherosclerosis 2000;152:531-532
9. Gerdhem P, Ivaska KK, Isaksson A, Pettersson K, Väänänen HK, Obrant KJ, et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 2007;22:127-134
10. Herrmann M, Wildemann B, Claes L, Klohs S, Ohnmacht M, Taban-Shomal O, et al. Experimental hyperhomocysteinemia reduces bone quality in rats. Clin Chem 2007;53:1455-1461 (Pubitemid 47206341)
11. Ozdem S, Samanci S, Tasatargil A, Yildiz A, Sadan G, Donmez L, et al. Experimental hyperhomocysteinemia disturbs bone metabolism in rats. Scand J Clin Lab Invest 2007;67:748-756
12. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005;51: 2348-2353
13. Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006;21:1003-1011
14. Herrmann M, Peter Schmidt J, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, et al. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 2007;45:1621-1632
15. Banse X, Sims TJ, Bailey AJ. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 2002;17:1621-1628
16. Oxlund H, Barckman M, Ortoft G, Andreassen TT. Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 1995;17(Suppl):365-371
17. McKusick VA, editor. Heritable disorders of connective tissue, 3rd ed. St. Louis: C.V. Mosby, 1966, 155 pp.
18. Saito M, Fujii K, Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 2006; 79:160-168
19. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, et al. DACH-LIGA Homocystein e.V. DACH-LIGA homocystein (German, Austrian and Swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003;41:1392-1403 (Pubitemid 37493551)
20. Kukla C, Gaebler C, Pichl RW, Prokesch R, Heinze G, Heinz T. Predictive geometric factors in a standardized model of femoral neck fracture experimental study of cadaveric human femurs. Injury 2002;33:427-433
21. Björkström S, Goldie IF. Hardness of the subchondral bone of the patella in the normal state, in chondromalacia, and in osteoarthrosis. Acta Orthop Scand 1982;53:451-462
22. Weingraber H, editor. Technische Härtemessung, 1st ed. München: C. Hanser Verlag, 1952, 383 pp.
23. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2:595-610.
24. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-1767
25. Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality. Bone 2006;39:1173-1181
26. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. J Am Med Assoc 2002;288:1889-1897 (Pubitemid 35168145)
27. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996;312:1254-1259
28. Morris MS, Jacques PF, Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 2005;37:234-242
29. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women. Clin Chem Lab Med 2005;43:1118-1123
30. Small RE. Uses and limitations of bone mineral density measurements in the management of osteoporosis. MedGenMed 2005;7:3.
31. Zioupos P, Currey JD, Hamer AJ. The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 1999;45:108-116
32. Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 2004;34:195-202.
33. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 2000;11 (Suppl):2-17.
34. Herrmann M, Wildemann B, Wagner A, Wolny M, Schorr H, Taban-Shomal O, et al. Experimental folate and fitamin B12 deficiency does not alter bone quality in rats. J Bone Miner Res 2009;24:589-596
35. Selhub J, Jacques PF, Bostom AG, Wilson PW, Rosenberg IH. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev 2000;28:117-145
36. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
37. Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 2007;8:17-31.
38. Nilsson-Ehle H, Landahl S, Lindstedt G, Netterblad L, Stockbruegger R, Westin J, et al. Low serum cobalamin levels in a population study of 70- and 75-year-old subjects. Gastrointestinal causes and hematological effects. Dig Dis Sci 1989;34: 716-723
39. Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-476
40. Hunter DJ, Spector TD. The role of bone metabolism in osteoarthritis. Curr Rheumatol Rep 2003;5:15-19
41. Dequeker J, Aerssens J, Luyten FP. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res 2003;15:426-439
42. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999;69:482-489
43. Herrmann W, Schorr H, Bodis M, Knapp JP, Muller A, Stein G, et al. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects. Eur J Clin Invest 2000;30:1083-1089